International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 5

Glycosylation Should Be Treated as Pharmacology Rather Than Decoration in Computational Models of Natural Product Exposure, Recognition, Transport, and Bioactivity
Download PDF


, ,
  1. Department of Glycosylation Pharmacology and Computational Modeling, School of Pharmacy, University College Cork, Cork, Ireland.
  2. Department of Recognition, Transport, and Bioactivity of Glycosylated Natural Products, Faculty of Pharmacy, University of Galway, Galway, Ireland.
Citation
Vancouver
O'Connor P, Murphy G, Walsh N. Glycosylation Should Be Treated as Pharmacology Rather Than Decoration in Computational Models of Natural Product Exposure, Recognition, Transport, and Bioactivity. Int J Pharm Phytopharmacol Res. 2025;15(5):111-9. https://doi.org/10.51847/DcBIjoO69G
APA
O'Connor, P., Murphy, G., & Walsh, N. (2025). Glycosylation Should Be Treated as Pharmacology Rather Than Decoration in Computational Models of Natural Product Exposure, Recognition, Transport, and Bioactivity. International Journal of Pharmaceutical And Phytopharmacological Research, 15(5), 111-119. https://doi.org/10.51847/DcBIjoO69G
Download citation:   EndNote   RIS
Article Link:
Downloads: 30
Views: 81
Abstract

Natural-product glycosides are frequently represented computationally as scaffold variants whose sugar residues can be removed, simplified, or treated primarily as modifiers of bulk physicochemical properties. That simplification is sometimes reasonable, but it can also erase pharmacologically consequential information. This conceptual article examines glycosylation as a state variable that can alter molecular conformation, chemical stability, gastrointestinal transformation, epithelial transport, systemic chemical identity, cellular exposure, and target recognition. The central argument is not that glycosylation has a uniform directional effect, but that the sugar, linkage, substitution pattern, and transformation context may determine which molecular species should actually be modeled. A proposed glycosylation-aware pharmacology framework therefore treats an administered glycoside, its aglycone, conjugates, and microbially or enzymatically generated products as context-dependent members of an exposure–recognition hypothesis rather than interchangeable structures.

The same logic extends to computation: topology-aware encodings, carbohydrate-sensitive force fields, explicit metabolite-state enumeration, and task-specific validation may be required when sugar chemistry governs the biological question. Conversely, aglycone-centered modeling remains defensible when presystemic conversion is dominant or the sugar does not materially alter exposure or recognition. The framework is intended to improve mechanistic discipline, not to establish a validated prediction rule. Its principal limitation is the heterogeneity of glycoside classes, transport systems, microbiomes, experimental models, and computational representations. Prospective matched glycoside–aglycone studies are required to determine when glycosylation materially changes prediction and lead interpretation.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.